Enhancement of Trans-Tympanic Drug Delivery by Pharmacological Induction of Inflammation.
drug delivery
histamine
inflammation
otitis media
trans-tympanic permeation
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
06 02 2023
06 02 2023
Historique:
pubmed:
13
1
2023
medline:
8
2
2023
entrez:
12
1
2023
Statut:
ppublish
Résumé
Drug delivery directly across the tympanic membrane (TM) could eliminate systemic exposure to antibiotics prescribed for otitis media, the most common reason for pediatricians to prescribe antibiotics. Here, we hypothesized that inducing inflammation of the TM could enhance drug flux across the TM. We demonstrated that the flux of ciprofloxacin across the TM was greatly increased by treatment with the proinflammatory agent histamine. That enhancement was blocked by concurrent treatment with blockers of histamine receptor 1. Treatment of the TM with histamine was able to enhance drug flux sufficiently to eradicate otitis media in vivo in chinchillas, but only if the histamine was applied prior to treatment with antibiotics.
Identifiants
pubmed: 36633440
doi: 10.1021/acs.molpharmaceut.2c00959
doi:
Substances chimiques
Histamine
820484N8I3
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM